Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: Diagnostic and prognostic features

Cancer

Volumn 110, Issue 2, 2007, Pages 265-274

  Faggiano, Antongiulio ^a   Sabourin, Jean Cristophe ^a   Ducreux, Michel ^a   Lumbroso, Jean ^a   Duvillard, Pierre ^a   Leboulleux, Sophie ^a   Dromain, Clarisse ^a   Colao, Annamaria ^b   Schlumberger, Martin ^a   Baudin, Eric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Epidemiology; Neuroendocrine carcinoma; Poorly differentiated large cell histotype; Prognostic factors; Survival

Indexed keywords

CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; PROTEIN BAX; PROTEIN BCL 2; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FRANCE; HUMAN; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG CARCINOMA; LYMPH NODE METASTASIS; MALE; METASTASIS; MITOSIS; NEUROENDOCRINE TUMOR; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 34547168084     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22791     Document Type: Article

References (20)

1. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25:458-511.
2. Rindi B, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behaviour. World J Surg. 1996;20: 168-172.
3. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934-944.
4. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut. 1998;43:422-427.
5. Solcia E, Kloeppel G, Sobin LH, eds. World Health Organization. International Histological Classification of Tumors: Histologic Typing of Endocrine Tumors. Berlin: Springer; 2000.
6. Travis WD, Linnoila MI, Tsokos MG, et al. Neuroendocrine tumours of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol. 1991;15:529-553.
7. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization. International Histological Classification of Tumors: Pathology and Genetics of Tumors of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press; 2004.
8. Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol. 1998;22:526-537.
9. Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Fujisawa T, Ohwada H. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer. 2001;91:1992-2000.
10. Mazieres J, Daste G, Molinier L, et al. Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer. 2002;37: 287-292.
11. Takei H, Asamura H, Maeshima A, et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg. 2002;124: 285-292.
12. Hage R, Seldenrijk K, de Bruin P, van Swieten H, van den Bosch J. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg. 2003;23:457-460.
13. Paci M, Cavazza A, Annessi V, et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg. 2004;77:1163-1167.
14. Filosso PL, Ruffini E, Oliaro A, et al. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide. J Thorac Cardiovasc Surg. 2005;129:819-824.
15. Gugger M, Burckhardt E, Kappeler A, Hirsiger H, Laissue JA, Mazzucchelli L. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol. 2002;196:408-415.
16. Walch AK, Zitzelsberger HF, Aubele MM, et al. Typical and atypical carcinoid tumors of the lung are characterized by llq deletions as detected by comparative genomic hybridization. Am J Pathol. 1998;153:1089-1098.
17. Anbazhagan R, Tihan T, Bornman DM, et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res. 1999;59:5119-5122.
18. Ullmann R, Petzmann S, Sharma A, Cagle PT, Popper HH. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol. 2001;32:1059-1063.
19. Sturm N, Rossi G, Lantuejoul S, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol. 2002;33:175-182.
20. Jones MH, Virtanen C, Honjoh D, et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet. 2004;363:775-781.